Director, Corporate Communications & Investor Relations at Atrium Therapeutics
Director, Corporate Communications & Investor Relations at Atrium TherapeuticsAtrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. Our proprietary technology leverages the targeted RNA delivery platform initially designed at Avidity, which combines the tissue selectivity of mAbs and other targeted delivery ligands with the precision of oligonucleotides.. Company Location: Boston, MA.